Cargando…
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
During the development of therapeutic microRNAs (miRNAs or miRs), it is essential to define their pharmacological actions. Rather, miRNA research and therapy mainly use miRNA mimics synthesized in vitro. After experimental screening of unique recombinant miRNAs produced in vivo, three lead antiproli...
Autores principales: | Chen, Yixin, Tu, Mei-Juan, Han, Fangwei, Liu, Zhenzhen, Batra, Neelu, Lara, Primo N., Chen, Hong-Wu, Bi, Huichang, Yu, Ai-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547963/ https://www.ncbi.nlm.nih.gov/pubmed/37799388 http://dx.doi.org/10.1016/j.apsb.2023.07.011 |
Ejemplares similares
-
In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
por: Li, Peng-Cheng, et al.
Publicado: (2021) -
A Study of Antimetabolites
Publicado: (1952) -
Problems in the Designing of Antimetabolites
por: Mautner, Henry G.
Publicado: (1960) -
Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
por: Biersack, Bernhard
Publicado: (2018) -
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
por: Dong, Linyinxue, et al.
Publicado: (2022)